PHARMACYTE BIOTECH, INC. Adjustments to Additional Paid in Capital, Warrant Issued
PHARMACYTE BIOTECH, INC. (PMCB) reported Adjustments to Additional Paid in Capital, Warrant Issued of $4.75 million for the 12-month period ending 2022-04-30, per its 10-K filed 2023-07-31.
Discontinued › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2023-07-31
- PHARMACYTE BIOTECH, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2021-10-31 was $4.75M.
- PHARMACYTE BIOTECH, INC. adjustments to additional paid in capital, warrant issued for fiscal 2022 was $4.75M.
- PHARMACYTE BIOTECH, INC. adjustments to additional paid in capital, warrant issued for fiscal 2015 was $1.15M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month as first filed |
|---|---|---|---|
| 2022-04-30 | $4.75M 10-K · filed 2023-07-31 | ||
| 2021-10-31 | $4.75M 10-Q · filed 2023-03-16 | ||
| 2015-04-30 | $1.15M 10-K · filed 2016-07-29 | $231.49K 10-K · filed 2015-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |